文献速递湿疹皮炎与荨麻疹皮肤感染

伴特应性表现的先天性免疫缺陷病中湿疹的频率、出现时机与表型聚类

Eczema in inborn errors of immunity with atopy: frequency, timing and phenotypic clustering.
PubMed 文献 · Br J Dermatol · 2026-01-01

该回顾性研究基于法国CEREDIH登记数据,纳入373例基因确诊的伴特应性表现的先天性免疫缺陷病(IEI-A)患者,分析湿疹频率、出现时机及表型。结果显示50.9%患者有湿疹,中位起病年龄4个月,湿疹频率与表现因基因型而异,并识别出4个表型聚类。湿疹常早于感染数年出现,38.4%湿疹患者符合英国工作组特应性皮炎诊断标准。

要点

  • IEI-A患者中湿疹常见且起病早(中位4个月),常早于严重感染数年出现。
  • 湿疹频率因基因型差异显著,DOCK8缺陷者全部受累,FOXP3和STAT3功能缺失者亦高发。
  • 识别特殊分布和严重瘙痒等表型特征有助于早期发现IEI-A。

核心结论

  • 湿疹是IEI-A常见且早期的临床特征,频率和表现因基因型而异。
  • 部分IEI-A相关湿疹临床表现有别于经典特应性皮炎,识别这些模式有助于早期诊断IEI-A。

研究设计与样本

  • 回顾性研究,使用法国国家原发性免疫缺陷病转诊中心(CEREDIH)数据。
  • 纳入373例基因确诊的IEI-A患者,来自三个大型CEREDIH参与中心且有可用临床数据。

主要发现

  • 373例IEI-A患者中50.9%(n=190)有湿疹。
  • DOCK8缺陷患者全部有湿疹,FOXP3缺陷者73%(n=22/30),STAT3功能缺失者75%(n=44/59)。
  • 湿疹起病通常较早,中位年龄4个月。
  • 识别出4个表型聚类,特殊部位和严重瘙痒与STAT3或DOCK8致病性变异强相关。
  • 190例湿疹患者中38.4%(n=73/190)符合英国工作组特应性皮炎诊断标准。

关键数值与推荐

  • 湿疹起病中位年龄4个月。
  • 38.4%(n=73/190)的IEI-A湿疹患者符合英国工作组特应性皮炎诊断标准。

临床怎么用

  • 对早发湿疹(尤其伴特殊分布或严重瘙痒)的儿童应警惕IEI-A,考虑基因检测。
  • DOCK8、FOXP3、STAT3相关IEI-A患者湿疹风险高,需密切监测。
  • 在启动系统性特应性皮炎治疗前,识别IEI-A相关湿疹模式可优化诊断和管理。

局限性

  • 回顾性研究设计。
  • 数据来自三个大型CEREDIH参与中心,可能存在选择偏倚。
  • 原文未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inborn errors of immunity (IEI) with atopy (IEI-A) are a subgroup of IEIs with eczema as a prominent clinical feature that can mimic atopic dermatitis (AD). However, IEI-A-associated eczema can differ from that of classic AD, and its frequency, genotype-specific clinical patterns and temporal relationships with other manifestations of IEI-A (infections, allergic manifestations, autoimmunity) remain poorly defined. OBJECTIVES: To characterize the frequency of eczema, timing and phenotypes in patients with IEI-A, and to explore the relationship of eczema with other clinical manifestations of IEI-A. METHODS: This retrospective study used data from the French National Referral Center for Primary Immunodeficiency Diseases (CEREDIH), focusing on patients with genetically defined IEI-A followed in three large CEREDIH-participating centres and available clinical data. Eczema frequency and onset in relationship to other clinical events, particularly severe-or-unusual infections, was assessed, as were eczema phenotypes, concomitant allergic manifestations, treatments and autoimmunity. Clustering analyses were computed to identify distinct IEI-A eczema-associated clinical phenotypes. RESULTS: Among 373 patients with IEI-A, varying widely by genotype, 50.9% (n = 190) had eczema. All patients deficient in DOCK8 (dedicator of cytokinesis-8) were affected, followed by those deficient in FOXP3 (n = 22/30; 73%) and those with STAT3 loss of function (n = 44/59; 75%). Onset was usually early (median 4 months). Eczema frequency and clinical presentation varied markedly across IEI-A genotypes; four phenotypic clusters were identified, with particular localizations and severe pruritus being strongly associated with pathogenic STAT3 or DOCK8 variants. For children with isolated eczema at 24 months, the risk of developing IEI-related severe or unusual infections was lower than that of persistent isolated eczema until the age of 6.8 years. CONCLUSIONS: Eczema is a common, early feature of IEI-A, often preceding infections by years. While 38.4% (n = 73/190) of patients with IEI-A with eczema fulfilled the UK Working Party diagnostic criteria for AD, some clinical pictures may differ from that of classic AD. At a time when systemic AD treatments are rapidly advancing in paediatrics, recognizing these patterns to identify patients with IEI-A could refine diagnostic strategies, improve IEI detection among children with eczema, shorten the time to IEI-A diagnosis, guide tailored management and ensure patients receive the optimal care. Inborn errors of immunity with atopy are rare inherited diseases of the immune system. We call them IEI-A for short. They can cause a particular type of eczema. This can often look like a common type of eczema called atopic dermatitis. We do not know a lot about how often eczema occurs in patients with IEI-A. We also do not know much about how it differs in patients with different genetic subtypes of IEI-A. Not much is known about when the eczema first appears compared with other symptoms like infections and allergies. We studied 373 people in France with genetically confirmed IEI-A. About half of the patients had eczema. How often people had eczema varied depending on the genetic cause. Eczema was particularly common in patients with diseases related to genes called ‘DOCK8’, ‘FOXP3’ and ‘STAT3’. Symptoms usually began very early in life (around 4 months of age). We identified several genetic patterns in eczema. Some patients with eczema had severe itching and unusual eczema locations. These symptoms were strongly associated with variants (or ‘mutations’) in STAT3 and DOCK8. Eczema often appeared years before severe or unusual infections developed. Children whose eczema appeared later in childhood had a higher risk of later developing infections of the immune system. The findings show that eczema can be an early warning sign of underlying immune conditions. Although many patients have eczema that looks like atopic dermatitis, some features separate IEI-A from common eczema. Understanding these better could help doctors diagnose these rare conditions earlier. This could improve patient management and ensure that children receive the best treatment.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Aubert H, Mahlaoui N, Barbarot S, et al. Eczema in inborn errors of immunity with atopy: frequency, timing and phenotypic clustering. Br J Dermatol. 2026. PMID: 42485622. doi:10.1093/bjd/ljag308

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。